Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2004-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/JC.2003-031033PMID 15001582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Somatomedin-1 (Recombinant Insulin-Like Growth Factor-1)

  2012cited by this paper
• Laron syndrome. First report from Greece.

  2003cited by this paper
• Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy X-ray absorptiometry and volumetric bone densities.

  2003cited by this paper
• Effects of Insulin-like Growth Factor-I Deficiency and Replacement Therapy on the Hematopoietic System in Patients with Laron Syndrome (Primary Growth Hormone Insensitivity)

  2003cited by this paper
• A Novel Mutation of the Growth Hormone Receptor Gene (GHR) in a Chinese Girl with Laron Syndrome

  2003cited by this paper
• Identification of two novel mutations in the human growth hormone receptor gene

  2003cited by this paper
• Pituitary size in patients with Laron syndrome (primary GH insensitivity).

  2003cited by this paper
• Growth hormone insensitivity associated with a STAT5b mutation.

  2003cited by this paper
• Reduced exercise capacity in untreated adults with primary growth hormone resistance (Laron syndrome)

  2003cited by this paper
• Novel Mutation Involving the Translation Initiation Codon of the Growth Hormone Receptor Gene (GHR) in a Patient with Laron Syndrome

  2002cited by this paper
• Craniofacial and brain abnormalities in Laron syndrome (primary growth hormone insensitivity).

  2002cited by this paper
• Effects of growth hormone and insulin-like growth factor 1 deficiency on ageing and longevity.

  2002cited by this paper
• Laron syndrome abnormalities: spinal stenosis, os odontoideum, degenerative changes of the atlanto-odontoid joint, and small oropharynx.

  2002cited by this paper
• IGF-I is critical for normal vascularization of the human retina.

  2002cited by this paper
• Intronic Mutation in the Growth Hormone Receptor Gene in a Peruvian Girl with Laron Syndrome

  2002cited by this paper
• Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study.

  2001cited by this paper
• Severe obstructive sleep apnoea syndrome in an adult patient with Laron syndrome.

  2001cited by this paper
• Consequences of not treating children with laron syndrome (primary growth hormone insensitivity).

  2001cited by this paper
• Characterisation of novel missense mutations in the GH receptor gene causing severe growth retardation.

  2000cited by this paper
• Comparison of the growth‐promoting effects of insulin‐like growth factor I and growth hormone in the early years of life

  2000cited by this paper
• Echocardiographic dimensions and function in adults with primary growth hormone resistance (Laron syndrome).

  2000cited by this paper
• Systematic review of N‐acetylcysteine in cystic fibrosis

  1999cited by this paper
• Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome).

  1999cited by this paper
• Growth hormone receptor deficiency in Ecuador.

  1999cited by this paper
• Is the Laron mouse an accurate model of Laron syndrome?

  1999cited by this paper
• Serum Insulin-like Growth Factor-I (IGF-I) Levels During Long-term IGF-I Treatment of Children and Adults with Primary GH Resistance (Laron Syndrome)

  1999cited by this paper
• A novel mutation affecting the interdomain link region of the growth hormone receptor in a Vietnamese girl, and response to long-term treatment with recombinant human insulin-like growth factor-I and luteinizing hormone-releasing hormone analogue.

  1998cited by this paper
• Development of hyperandrogenism during treatment with insulin‐like growth factor‐I (IGF‐I) in female patients with Laron syndrome

  1998cited by this paper
• Bone Mineral, Histomorphometry, and Body Composition in Adults with Growth Hormone Receptor Deficiency

  1998cited by this paper
• Normal intelligence with severe insulin-like growth factor I deficiency due to growth hormone receptor deficiency: a controlled study in a genetically homogeneous population.

  1998cited by this paper
• Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance).

  1998cited by this paper
• Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.

  1998cited by this paper
• Stature in Ecuadorians heterozygous for growth hormone receptor gene E180 splice mutation does not differ from that of homozygous normal relatives.

  1998cited by this paper
• Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a)

  1997cited by this paper
• Five Year Treatment with IGF-I of a Patient with Laron Syndrome in Slovenia (a Follow-up Report)

  1997cited by this paper
• Intronic Mutation in the Growth Hormone (GH) Receptor Gene from a Girl with Laron Syndrome and Extremely High Serum GH Binding Protein: Extended Phenotypic Study in a Very Large Pedigree

  1997cited by this paper
• A dominant-negative mutation of the growth hormone receptor causes familial short stature

  1997cited by this paper
• Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein.

  1997cited by this paper
• Nine novel growth hormone receptor gene mutations in patients with Laron syndrome.

  1997cited by this paper
• Peptide growth factors and preimplantation development.

  1997cited by this paper
• Muscle force and endurance in untreated and human growth hormone or insulin-like growth factor-I-treated patients with growth hormone deficiency or Laron syndrome.

  1997cited by this paper
• A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).

  1997cited by this paper
• Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome.

  1997cited by this paper
• Clinical, biochemical, and molecular investigations of a genetic isolate of growth hormone insensitivity (Laron's syndrome).

  1997cited by this paper
• Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.

  1997cited by this paper
• Insulin‐like growth factor‐I raises serum procollagen levels in children and adults with Laron syndrome

  1996cited by this paper
• Differential effect of insulin-like growth factor-I and growth hormone on hypothalamic regulation of growth hormone secretion in the rat

  1996cited by this paper
• A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein.

  1996cited by this paper
• Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene.

  1996cited by this paper
• Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.

  1996cited by this paper
• Laron syndrome: typical and atypical forms.

  1996cited by this paper
• Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient.

  1995cited by this paper
• Insulin-like growth factor I improves height in growth hormone insensitivity: two years' results.

  1995cited by this paper
• Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group.

  1995cited by this paper
• Three Year IGF-I Treatment of Children with Laron Syndrome

  1995cited by this paper
• Growth hormone insensitivity syndrome due to point deletion and frame shift in the growth hormone receptor.

  1995cited by this paper
• Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment.

  1995cited by this paper
• IGF‐I treatment of adult patients with Laron syndrome: preliminary results

  1994cited by this paper
• Renal function in Laron syndrome patients treated by insulin-like growth factor-I

  1994cited by this paper
• Comparative effects of GH, IGF‐I and insulin on serum sex hormone binding globulin

  1994cited by this paper
• A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH‐binding activity by abolishing receptor homodimerization.

  1994cited by this paper
• Growth hormone (GH) insensitivity due to primary GH receptor deficiency.

  1994cited by this paper
• Receptor mutations and haplotypes in growth hormone receptor deficiency: a global survey and identification of the Ecuadorean E180splice mutation in an oriental Jewish patient

  1994cited by this paper
• IGF-I treatment of adult patients with Laron syndrome: preliminary results.

  1994cited by this paper
• SPECTRUM OF GROWTH HORMONE RECEPTOR MUTATIONS AND ASSOCIATED HAPLOTYPES IN LARON SYNDROME

  1993cited by this paper
• Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity.

  1993cited by this paper
• Laron syndrome due to a post-receptor defect: response to IGF-I treatment.

  1993cited by this paper
• Modulation of insulin like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS).

  1993cited by this paper
• Diverse growth hormone receptor gene mutations in Laron syndrome.

  1993cited by this paper
• Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment.

  1993cited by this paper
• Growth curves for Laron syndrome.

  1993cited by this paper
• Classification of growth hormone insensitivity syndrome.

  1993cited by this paper
• Effect of insulin-like growth factor I on the thyroid axis in patients with Laron-type dwarfism and healthy subjects.

  1992cited by this paper
• Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study.

  1992cited by this paper
• Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature.

  1992cited by this paper
• Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome

  1992cited by this paper
• Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism.

  1992cited by this paper
• Serum prolactin in patients with Laron-type dwarfism: effect of insulin-like growth factor I.

  1992cited by this paper
• Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type)

  1992cited by this paper
• IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF‐I

  1992cited by this paper
• Erythrocytes from patients with low serum concentrations of IGF-I have an increase in receptor sites for IGF-I.

  1991cited by this paper
• Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism.

  1991cited by this paper
• Biochemical and hormonal changes induced by one week of administration of rIGF‐I to patients with Laron type dwarfism

  1991cited by this paper
• Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome.

  1991cited by this paper
• Picture of the month. Laron-type dwarfism.

  1991cited by this paper
• Elimination characteristics of intravenously administered rIGF-I in Laron-type dwarfs.

  1990cited by this paper
• Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

  1989cited by this paper
• SERUM GROWTH HORMONE BINDING PROTEIN ACTIVITY IN HEALTHY NEONATES, CHILDREN AND YOUNG ADULTS: CORRELATION WITH AGE, HEIGHT AND WEIGHT

  1989cited by this paper
• Laron dwarfism and mutations of the growth hormone-receptor gene.

  1989cited by this paper
• Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism.

  1989cited by this paper
• Growth hormone (hGH) secretion and turnover in three patients with Laron-type dwarfism.

  1988cited by this paper
• Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism.

  1988cited by this paper
• Growth hormone receptor and serum binding protein: purification, cloning and expression

  1987cited by this paper
• Absence of the plasma growth hormone-binding protein in Laron-type dwarfism.

  1987cited by this paper
• Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).

  1987cited by this paper
• Identification and characterization of specific binding proteins for growth hormone in normal human sera.

  1986cited by this paper
• A specific growth hormone-binding protein in human plasma: initial characterization.

  1986cited by this paper
• Some properties of the plasma hGH activity in patients with Laron-type dwarfism determined by a radioreceptor assay using human liver tissue.

  1985cited by this paper
• Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism.

  1984cited by this paper
• Laron-type dwarfism (hereditary somatomedin deficiency): a review.

  1984cited by this paper

• Near-Adult Height Outcomes in Patients Treated With rhIGF-1 for Severe Growth Failure: Real-World IGFD Registry Data

  2025cites this paper
• Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications.

  2025cites this paper
• Disabilities and Handicaps of Patients with Laron Syndrome

  2025cites this paper
• Häufige und seltene Ursachen von Kleinwuchs: Bedeutung der genetischen Diagnostik

  2025cites this paper
• Precision medicine, insulin-like growth factors and cancer therapy

  2025cites this paper
• Transient juvenile hypoglycemia in GH insensitive Laron syndrome pigs is associated with insulin hypersensitivity

  2025cites this paper
• Decreased β-cell volume and insulin secretion but preserved glucose tolerance in a growth hormone insensitive pig model

  2024cites this paper
• An unusual brain lesion in a patient with Laron Syndrome

  2024cites this paper
• Characterization of Primary IGF-1 Deficiency in a Cohort of Canadian Children with Short Stature Using a Novel Algorithm Tailored to Electronic Medical Records

  2024cites this paper
• The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency

  2024cites this paper
• Adult patients with Laron syndrome tend to develop the metabolic syndrome.

  2024cites this paper
• Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspective

  2023cites this paper
• Occupation, Literacy, Anthropometric Traits, and Life Expectancy of Italian Men Born 1900–1910: Evidence From Military Conscription Registers

  2023cites this paper
• Frequency and Predictive Factors of Hypoglycemia in Patients Treated With rhIGF-1: Data From the Eu-IGFD Registry

  2023cites this paper
• Insulin-like growth factors and aging: lessons from Laron syndrome

  2023cites this paper
• Structural and proteomic repercussions of growth hormone receptor deficiency on the pituitary gland: Lessons from a translational pig model

  2023cites this paper
• Antagonistic pleiotropy: the example of cardiac insulin-like growth factor signaling, which is essential in youth but detrimental in age

  2023cites this paper
• Idiopathic Short Stature: What to Expect from Genomic Investigations

  2023cites this paper
• Tmem263 deletion disrupts the GH/IGF-1 axis and causes dwarfism and impairs skeletal acquisition

  2023cites this paper
• Clinical profile of Laron dwarfism – experience from a tertiary care institute in Chennai

  2023cites this paper
• Clinical-genetic analysis of selected genes involved in the development of the human skeleton in 128 Czech patients with suspected congenital skeletal abnormalities.

  2023cites this paper
• The Impact of Westernization on the Insulin/IGF-I Signaling Pathway and the Metabolic Syndrome: It Is Time for Change

  2023influential citation
• Challenges in Pediatric Endocrinology

  2023cites this paper
• Laron syndrome in South Indian children – A descriptive study

  2023cites this paper
• An Attempt to Identify the Medaka Receptor for Somatolactin Alpha Using a Reverse Genetics Approach

  2023cites this paper
• Laron Syndrome: A Tale of Two Siblings

  2023cites this paper
• Three Siblings With Woodhouse-Sakati Syndrome: A Case Report of A New Saudi Family

  2022cites this paper
• Alterations in Stem Cell Populations in IGF-1 Deficient Pediatric Patients Subjected to Mecasermin (Increlex) Treatment

  2022cites this paper
• Treatment for Infertility in Laron Syndrome: A Case Report

  2022cites this paper
• Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP

  2022cites this paper
• Delayed Puberty Phenotype Observed in Noonan Syndrome Is More Pronounced in Girls than Boys

  2022cites this paper
• Focal Epilepsy in Individuals with Laron Syndrome

  2022cites this paper
• Dental arches in inherited severe isolated growth hormone deficiency.

  2022cites this paper
• First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model

  2022cites this paper
• Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action

  2022cites this paper
• Systemic Deficiency of GHR in Pigs leads to Hepatic Steatosis via Negative Regulation of AHR Signaling

  2021cites this paper
• Laron syndrome: An experience of treatment of two cases

  2021cites this paper
• Hypoglycemia in the Toddler and Child

  2021cites this paper
• Organization of the mammalian hypothalamus-pituitary axes

  2021cites this paper
• Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: A Novel Cause of Severe Growth Hormone Insensitivity

  2021cites this paper
• The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway

  2021cites this paper
• Hormone resistance and short stature: A journey through the pathways of hormone signaling.

  2021cites this paper
• Zika virus dysregulates the expression of astrocytic genes involved in neurodevelopment

  2021cites this paper
• Identification and In Vitro Functional Verification of Two Novel Mutations of GHR Gene in the Chinese Children with Laron Syndrome

  2021cites this paper
• Disorders of Childhood Growth

  2021cites this paper
• Role of the GH-IGF1 axis on the hypothalamus–pituitary–testicular axis function: lessons from Laron syndrome

  2021cites this paper
• Genetic Characterization of Short Stature Patients With Overlapping Features of Growth Hormone Insensitivity Syndromes

  2021influential citation
• A novel peptide antagonist of the human growth hormone receptor

  2021cites this paper
• Growth hormone assays and dynamic tests in the diagnosis of acromegaly and GH deficiency in adults

  2021cites this paper
• MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression

  2021cites this paper
• Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age

  2021cites this paper
• Hormone resistance in children: what primary care physicians need to know

  2021cites this paper
• Clinical Profiles and Genetic Spectra of 814 Chinese Children With Short Stature

  2021cites this paper
• Significance of Direct Confirmation of Growth Hormone Insensitivity for the Diagnosis of Primary IGF-I Deficiency

  2020cites this paper
• Identification of nephronectin as a new target for IGF1 action.

  2020cites this paper
• Growth hormone receptor knockout: Relevance to xenotransplantation

  2020cites this paper
• Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation

  2020cites this paper
• Abnormal Fetal Growth

  2020cites this paper
• IGF-I deficiency and enhanced insulin sensitivity due to a mutated growth hormone receptor gene in humans.

  2020cites this paper
• Pituitary Gland Signs

  2020cites this paper
• Hormone Effects on Tumors

  2020cites this paper
• Role of the GH-IGF1 system in progression of cancer.

  2020cites this paper
• Laron syndrome – A historical perspective

  2020cites this paper
• Laron syndrome.

  2020cites this paper
• Endocrine Pathophysiology: A Concise Guide to the Physical Exam

  2020cites this paper
• GHR and IGF2R genes may contribute to normal variations in craniofacial dimensions: Insights from an admixed population.

  2020cites this paper
• Functional changes of the liver in the absence of growth hormone (GH) action – Proteomic and metabolomic insights from a GH receptor deficient pig model

  2020cites this paper
• Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome

  2020cites this paper
• Association of the P561T and C422F polymorphisms of the growth hormone receptor gene with facial dimensions.

  2020cites this paper
• Erratum: Laron syndrome

  2020cites this paper
• Effects of GH/IGF on the Aging Mitochondria

  2020cites this paper
• Changes in plasma amino acids metabolites, caused by long-term IGF-I deficiency, are reversed by IGF-I treatment - A pilot study.

  2020cites this paper
• Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer

  2019cites this paper
• A novel homozygous point mutation and deletion in exon 3 of growth hormone receptor causes laron syndrome: A case study

  2019cites this paper
• Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways

  2019cites this paper
• Genetic causes of isolated short stature

  2019cites this paper
• Update on new GH-IGF axis genetic defects

  2019cites this paper
• The effects of growth hormone on therapy resistance in cancer

  2019cites this paper
• Ribosomal DNA harbors an evolutionarily conserved clock of biological aging

  2019cites this paper
• A Case with Laron Syndrome

  2019cites this paper
• Determining the Efficacy of Insulin for use in Factor Delivery Device for Tendon Healing and Regeneration

  2019cites this paper
• Growth Hormone insensitivity (Laron syndrome): Report of a new family and review of Brazilian patients

  2019cites this paper
• ECHOES OF THEATRICAL PERFORMANCES IN MEDIEVAL ARMENIA ON ARCHAEOLOGICAL AND ANTHROPOLOGICAL MATERIALS OF THE DVIN CITY

  2019cites this paper
• REUNIÓN CON EL EXPERTO Cirugía bariátrica en adolescentes

  2019cites this paper
• Low Serum IGF-1 in Boys with Recent Onset of Juvenile Idiopathic Arthritis

  2018cites this paper
• Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation.

  2018cites this paper
• Der Effekt von Wachstumshormon auf die menschlichen Alterungsprozesse. Teil 1

  2018cites this paper
• Laron Syndrome Patients have an Abnormal Plasma Amino Acid Pattern

  2018cites this paper
• Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action.

  2018cites this paper
• Der Effekt von Wachstumshormon auf die menschlichen Alterungsprozesse. Teil 1

  2018cites this paper
• Cardiac examination in children with Laron syndrome undergoing mecasermin therapy

  2018cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects?

  2018cites this paper
• Generation and characterization of a pig model for Laron syndrome

  2018influential citation
• Differential tissue response to growth hormone in mice

  2018cites this paper
• Clusters of genetic diseases in Brazil

  2018cites this paper
• Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1

  2018cites this paper
• Growth Hormone Deficiency: Health and Longevity.

  2018cites this paper
• Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action

  2018cites this paper
• Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver

  2018influential citation
• Human Placental Growth Hormone Variant in Pathological Pregnancies.

  2018cites this paper